Amine MAROUF

NaoX Technologies est une startup française lancée en 2018 par Hugo DINH, Polytechnicien et Michel LE VAN QUYEN, expert en neuroscience à lInserm. Notre mission est de démocratiser la prévention de troubles neurologiques.

Poppins, at the intersection of music, education and health, develops tools for therapeutic continuity for children with neurodevelopmental disorders, particularly dys disorders. Built around rhythmic and auditory stimuli (applicable to many neurodevelopmental pathologies), we have a strong use of music thanks to our partners (Warner / Disney / Sony...), to create a rich, non-medicated and non-stigmatizing experience for the child. Our job is to work alongside health professionals by accompanying the child in his or her therapeutic journey at home. Poppins was founded at École Polytechnique in 2018 and has grown in France and Los Angeles (Techstars US). As a partner of the French Federation of Learning Disorders, we have been able to accompany more than 15000 young children with learning disabilities.

Lucine is part of Butterfly Therapeutics since december 2023. Lucine is an expert in women’s pelvic pain relief, and we’re on a mission to change women’s lives. We offer an evidence-based approach with scientifically proven solutions that reduce & relieve pain related to endometriosis, periods, menopause, post-partum discomfort, and more. Endocare is our clinically-tested, patented medical device that directly targets pain mechanisms with a unique combination of visual and sound frequencies Lets work together, changing womens lives !

FeetMe is a digital health & remote patients monitoring company developing innovative connected technologies and services to improve patient outcomes in functional care, track disease evolution, and optimize medication utilization. www.feetme.fr. The innovative technology from FeetMe allows gait and posture analysis in real-time and real-life conditions. The technology combines pressure sensors, motion sensors and learning algorithms to analyse patients’ functional capacity, as well as empower rehabilitation among sufferers of gait disorders. Find more infos about open job offers http://jobs.feetme.fr

Fundraising shouldnt be a black box. Peachdeck built the first deterministic AI engine that scores pitch decks and matches founders to the right investors — no LLM guesswork, just a real scoring pipeline calibrated on actual VC outcomes. For founders: know exactly where your deck stands, before you send it. For investors: triage deal flow in minutes, not hours. For juries: score every pitch in a competition on the same fair, reproducible scale. For students and academic professionals: bring investor-grade rigor into the classroom.

Spinova Ventures turns dormant R&D inside mid-market industrial and healthcare companies into independent, investable ventures. Most of these companies hold research that never reached a market: a process developed for one client, a prototype that outgrew its original use, a patent filed and shelved. It sits on the balance sheet, it costs money to maintain, and it competes for attention with the core business. Selling it is complicated. Building a business unit around it is expensive. So nothing happens. We build the third option. Spinova takes one non-core asset and structures it as a ring-fenced NewCo, designed from day one around a real market need, an investable equity story and the constraints of the parent company. The parent keeps its optionality, including the right to come back in, and carries none of the operating drag. We call these born-to-fit ventures. They are not incubated and then sold a fit. They are built to have one. The first step is a capped six-week scan. One asset, a fee agreed upfront, and a written answer: is there a venture here, what would it be worth, what would it take, and what the parent keeps. At the end you decide, on evidence, with no obligation to go further. Spinova Ventures is operated by AZAM, the advisory firm founded by Amine Marouf, previously Principal at Kurma Partners and Investment Director for VC HealthTech at BNP Paribas Développement, and an expert for Bpifrance under France 2030 and for EIT Health. If you hold research you are not exploiting, book a scan at spinovaventures.com.

AZAM is an independent advisory firm for HealthTech, MedTech and biopharma companies facing a transaction: divestitures, acquisitions, fundraising, and the preparation that decides the outcome long before the first investor meeting. Most founders and owners run one or two transactions in their working life. The people on the other side of the table run several a month. We close that gap. We prepare the file, we build the case the way an investment committee actually reads it, we identify and approach the right counterparties, and we run the process through to closing. The practice is led by Amine Marouf. Seven and a half years at Kurma Partners as Principal, around 800 opportunities reviewed a year and seed investments across Europe in diagnostics, monitoring and digital health. Then Investment Director, VC HealthTech, at BNP Paribas Developpement. He sits on Bpifrance juries under the France 2030 programme and is an expert for EIT Health. That is the point: your file is built by someone who spent seven years assessing files like it from the investors chair. AZAM works directly and alongside Scale4Health, KingsRock and Tesuji, on mandates in France, EU, UK and US AZAM also operates Spinova Ventures, which turns dormant R&D inside mid-market industrial companies into independent, investable spin-outs. If you are preparing a sale, an acquisition or a round, the most useful conversation is the one before you start.

BNP Paribas Développement, filiale autonome du groupe bancaire international BNP Paribas, est une société anonyme qui investit directement ses fonds propres pour soutenir le développement des PME et ETI performantes et assurer leur pérennité en facilitant leur transmission, en qualité d’actionnaire minoritaire.

BNP Paribas is a leading bank in Europe with an international reach. It has a presence in 64 countries, with more than 178,000 employees, including more than 144,000 in Europe. BNP Paribas holds leading positions in its three major operating divisions: ⚆ Commercial, Personal Banking & Services for all the Group’s retail banking networks and several specialised businesses, including BNP Paribas Personal Finance and Arval; ⚆ Investment & Protection Services for savings, investment and protection solutions; ⚆ Corporate & Institutional Banking, which is focused on corporate and institutional clients. The Group helps all its clients (individuals, community associations, entrepreneurs, SMEs, corporates and institutional clients) to realise their projects through solutions spanning financing, investment, savings and protection insurance. In Europe, the Group has four domestic markets (Belgium, France, Italy and Luxembourg) and BNP Paribas Personal Finance is the European leader in consumer lending. BNP Paribas is rolling out its integrated retail-banking model in Mediterranean countries, in Turkey, in Eastern Europe and a large network in the western part of the United States. In its Corporate & Institutional Banking and Investment & Protection Services activities, BNP Paribas also enjoys top positions in Europe, a strong presence in the Americas as well as a solid and fast-growing business in Asia-Pacific. To learn more about our social media terms and Data Protection Notice: https://group.bnpparibas/en/data-protection